Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational radiopharmaceutical therapy Lutetium (177Lu) rhPSMA-10.1 Injection in an ...
St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback